ArticleMolecular therapy : the journal of the American Society of Gene Therapy2019

Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice.

Li Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.